Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age

The Journal of Pediatrics

Volumn 118, Issue 2, 1991, Pages 184-190

  Parke Jr , James C ^a,b,c,d   Schneerson, Rachel ^a,b,c,d   Reimer, Charles ^a,b,c,d   Black, Charlotte ^a,b,c,d   Welfare, Sandy ^a,b,c,d   Bryla, Dolores ^a,b,c,d   Levi, Lily ^a,b,c,d   Pavliakova, Danka ^a,b,c,d   Cramton, Tod ^a,b,c,d   Schulz, Dominique ^a,b,c,d   Cadoz, Michel ^a,b,c,d   Robbins, John B ^a,b,c,d  

^a CAROLINAS MEDICAL CENTER   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Pasteur Merieux Serums et Vaccins   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS TOXOID;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEVER; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOGENICITY; INFANT; IRRITABILITY; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; VACCINATION;

ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOGLOBULINS; INFANT; MENINGITIS, HAEMOPHILUS; TETANUS TOXOID; TWINS;

EID: 0026058025     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(05)80480-9     Document Type: Article

References (18)

1. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates
2. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody response to the Haemophilus influenzae type b capsular polysaccharide in human infants
3. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy
4. Isoelectric focusing of human antibody to the Haemophilus influenzae type b capsular polysaccharide: restricted and identical spectrotypes in adults
5. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide
6. Clinical and immunological responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children
7. Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18–24 months of age
8. Four conjugate Haemophilus b vaccines in infants: a comparative trial
9. Quantitative measurement of “natural” and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies
10. Affinity purification of IgG subclasses and distribution of thyroid antoantibody reactivity in Hashimoto's thyroiditis
11. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae capsular polysaccharide-tetanus toxoid conjugate
12. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
13. Comparison of active and combined passive/active immunization of Navajo children against Haemophilus influenzae type b
14. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A polysaccharide-protein conjugates
15. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children
16. Quantitative and qualitative analyses of serum Haemophilus influenzae type b, pneumococcus type 6A and tetanus toxin antibodies elicited by polysaccharide-protein conjugates in adult volunteers
17. Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria